These novel therapies , Semaglutide , represent a remarkable advancement in addressing metabolic dysfunction and potentially other disorders. They all are grouped as GLP-1 pathway activators , indicating these substances to emulate the body's GLP-1 hormone , stimulating glucose production and sup